Livability Magazine recently highlighted KeraNetics™ as one of the leading bioscience companies in Winston-Salem. KeraNetics™ was highlighted for its bioscience advancements on treating and managing radiation burns. Additionally, FDA approval for our KeraStat® Cream to help manage wounds and skin toxicities, like radiation dermatitis, was noted as a significant achievement.
KeraStat® Cream is intended to manage dermatology wounds and skin toxicities. These types of wounds and toxicities can include radiation dermatitis that occurs as a side effect of breast cancer radiotherapy treatment. Federal law restricts the sale of KeraStat® Cream to sale by or on the order of a physician.